Back to Trials
Accepting PatientsObservationalNCT07876349

EHR Intervention to Increase HBOC Genetic Testing

Breast Cancer, Ovarian Cancer

Phase:Observational
Status:Accepting Patients
Age:21 - 75
Gender:Female
Locations:1 site

What This Study Is About

The purpose of this research study is to test how well a new approach - using tools built into the electronic health record (EHR)- can help increase genetic testing for hereditary breast and ovarian cancer (HBOC) in women who have a family history that puts them at higher risk. The study will also look at what helps or gets in the way of using these tools in everyday clinical care. As part of this study, the investigators are also evaluating a website called RealRisks, which is designed to support patients in understanding their risk and making informed decisions about genetic testing. By studying how patients and primary care providers use this tool, the investigators hope to improve the way decision support tools are used to guide conversations and decisions about HBOC testing.

Who Can Participate

You May Qualify If
  • Women, age 21-75 years
  • Completed Six-Point Scale (SPS) family history screener with a score of 6 or higher.
  • Seen in NewYork Presbyterian primary care clinic selected for pilot testing
  • No personal history of breast or ovarian cancer
  • No prior germline HBOC genetic testing
  • +3 more...
You Cannot Join If
  • \- Patients who previously participated in the development studies for RealRisks and BNAV.
Key Requirements
  • Age 21-75 years
  • Able to provide informed consent
View Full Eligibility Criteria
Full Criteria (from ClinicalTrials.gov)

Inclusion Criteria: * Women, age 21-75 years * Completed Six-Point Scale (SPS) family history screener with a score of 6 or higher. * Seen in NewYork Presbyterian primary care clinic selected for pilot testing * No personal history of breast or ovarian cancer * No prior germline HBOC genetic testing * English or Spanish-speaking * Access to a smartphone, tablet, or computer * Able to provide written, verbal, or online informed consent Exclusion criteria: \- Patients who previously participated in the development studies for RealRisks and BNAV.

Important: This is a summary. The final determination of eligibility will be made by the trial coordinator after reviewing your complete medical history.

Study Locations

Columbia University Irving Medical Center — New York, New York

Contact

Contact

Research Nurse Navigator

Experimental Treatment

This trial is testing a new treatment. Results are not guaranteed. Talk to your doctor before applying.

Apply to This Trial

Your information will be sent to the study coordinator for review.